Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-04-07

Clinical Trial Update: Treatment of High Risk Adult Acute Lymphoblastic Leukemia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for high-risk adult acute lymphoblastic leukemia sponsored by PETHEMA Foundation; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: PETHEMA Foundation | Conditions: Acute Lymphoblastic Leukemia | Phase 4 | Status: COMPLETED